Company / Cost of Revenue
Glaukos Corp. Cost of Revenue History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cost of Revenue
$111.8M
FY2025
5-year range
$66.6M / $111.8M
FY2021-FY2025
Trend
+18.9%
vs FY2024
Sector context
#86 of 107
Health Care
What the data says
Glaukos Corp.'s cost of revenue of $112M is lower than 80% of companies in the Health Care sector (FY2025). Cost of Revenue has increased for 4 consecutive years, from $67M in FY2021 to $112M in FY2025.
Based on SEC 10-K filings.
$112M in FY2025 with a 5-year CAGR of +4.0%.
Increased from $76M to $112M over the past 2 years.
Health Care sector context is included.
Cost of Revenue over time
Growth rates
- 3-Year CAGR
- +17.5%
- 5-Year CAGR
- +4.0%
- 10-Year CAGR
- -
Sector benchmark
Top 20% in Health CareTop 20% of 107This company $111.8M Sector average $11.8B
▼
-99.1% below sector average
Key checks
Key Insights
- Glaukos Corp.'s cost of revenue has grown for 4 consecutive years.
- 5-year CAGR of +4.0%, indicating consistent growth.
- In FY2025, cost of revenue increased 18.9% year-over-year.
- Ranks #86 out of 107 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 0.45 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cost of RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $111.8M | +18.9% |
| FY2024 | $94.0M | +24.4% |
| FY2023 | $75.6M | +9.6% |
| FY2022 | $69.0M | +3.5% |
| FY2021 | $66.6M | -27.4% |
| FY2020 | $91.7M | +137.7% |
| FY2019 | $38.6M | +53.9% |
| FY2018 | $25.1M | +19.1% |
| FY2017 | $21.1M | +30.1% |
| FY2016 | $16.2M | +24.6% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026